IRIS UniCatt

Lepore, Domenico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.176
NA - Nord America 1.098
AS - Asia 415
SA - Sud America 44
AF - Africa 4
OC - Oceania 1
Totale 2.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.083
DE - Germania 482
SE - Svezia 190
SG - Singapore 153
CN - Cina 132
IT - Italia 106
UA - Ucraina 89
FR - Francia 86
GB - Regno Unito 47
FI - Finlandia 46
IE - Irlanda 46
BR - Brasile 40
IN - India 33
ID - Indonesia 30
RU - Federazione Russa 22
BE - Belgio 16
HK - Hong Kong 15
TR - Turchia 12
IR - Iran 10
JP - Giappone 7
CZ - Repubblica Ceca 6
ES - Italia 6
MX - Messico 6
PL - Polonia 6
TW - Taiwan 6
AT - Austria 5
CA - Canada 5
NL - Olanda 5
PH - Filippine 5
GR - Grecia 4
LT - Lituania 4
PT - Portogallo 4
BD - Bangladesh 3
AR - Argentina 2
CH - Svizzera 2
CL - Cile 2
DZ - Algeria 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
IQ - Iraq 1
JM - Giamaica 1
KG - Kirghizistan 1
KR - Corea 1
LU - Lussemburgo 1
NO - Norvegia 1
PA - Panama 1
RO - Romania 1
TH - Thailandia 1
TN - Tunisia 1
Totale 2.738
Salva come PNG Salva come JPEG
Città #
Chandler 267
Singapore 104
Ashburn 59
Ann Arbor 56
Jacksonville 55
San Mateo 49
Dublin 44
Marseille 39
New York 38
Los Angeles 36
Jakarta 30
Milan 29
Nanjing 29
Helsinki 28
Boston 25
Wilmington 22
Nanchang 21
Princeton 20
Woodbridge 20
Dearborn 19
Cattolica 18
Munich 18
Nürnberg 17
Brussels 16
Houston 15
Moscow 15
Hong Kong 14
Redmond 14
Rome 14
Augusta 12
Beijing 12
Fairfield 12
Pune 11
Lancaster 9
Lawrence 9
Andover 8
Izmir 8
Seattle 8
Bremen 6
Detroit 6
Düsseldorf 6
Hebei 6
Leawood 6
Redwood City 6
Taichung 6
Boardman 5
Brno 5
Hangzhou 5
Kish 5
Shenyang 5
The Dalles 5
Tokyo 5
University Park 5
Busto Arsizio 4
Frankfurt am Main 4
Fremont 4
Kunming 4
Madrid 4
Pescara 4
Tianjin 4
Changchun 3
Changsha 3
Fuzhou 3
Kraków 3
London 3
Shanghai 3
Vienna 3
Calgary 2
Columbus 2
Dhaka 2
Hyderabad 2
Jiaxing 2
Lappeenranta 2
Lauterbourg 2
Mexico City 2
Monmouth Junction 2
Mountain View 2
Norwalk 2
Novosibirsk 2
Nuremberg 2
Orta di Atella 2
Paris 2
Pavia 2
Provo 2
Santa Clara 2
São Paulo 2
Taizhou 2
Tashkent 2
Vila Velha 2
Warsaw 2
Washington 2
Arantina 1
Arapiraca 1
Araruama 1
Ardabil 1
Atlanta 1
Bananeiras 1
Baotou 1
Basra 1
Belo Horizonte 1
Totale 1.408
Salva come PNG Salva come JPEG
Nome #
Cortical visual function in preterm infants in the first year. 219
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 172
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 167
Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity. 156
Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. 150
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 139
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 110
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia 110
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 107
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity 103
A cost effectiveness analysis of cataract surgery 103
An epidemiological analysis of retinopathy of prematurity over 10 years. 101
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 96
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: Incidence, presentation, and management of complications during general anesthesia 95
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 86
Early visual and neuro-development in preterm infants with and without retinopathy 85
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 73
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates. 67
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 66
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 60
The role of retinal imaging in the management of abusive head trauma cases 58
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 57
Bilateral fixed mydriasis reversible during orthopedic surgery in the prone position 48
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial 43
Convolutional neural network based on fluorescein angiography images for retinopathy of prematurity management 43
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea 42
Taser-Related Ocular Injuries: A Review of the Literature and Medico-Legal Implications 40
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY 40
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply 36
Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) 33
Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis 11
International Classification of Retinopathy of Prematurity, Third Edition 10
Cord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial 10
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial 9
2-year outcomes of ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW extension study): prospective follow-up of an open label, randomised controlled trial 8
Intravitreal Aflibercept vs Laser Therapy for Retinopathy of Prematurity Two-Year Efficacy and Safety Outcomes in the Nonrandomized Controlled Trial FIREFLEYE next 7
Time Course of Retinopathy of Prematurity Regression and Reactivation After Treatment with Ranibizumab or Laser in the RAINBOW Trial 6
Ranibizumab population pharmacokinetics and free vegf pharmacodynamics in preterm infants with retinopathy of prematurity in the rainbow trial 6
Systemic exposure to aflibercept after intravitreal injection in premature neonates with retinopathy of prematurity: results from the FIREFLEYE randomized phase 3 study 6
Effect of Intravitreal Aflibercept vs Laser Photocoagulation on Treatment Success of Retinopathy of Prematurity: The FIREFLEYE Randomized Clinical Trial 5
P Score: A Reference Image-Based Clinical Grading Scale for Vascular Change in Retinopathy of Prematurity 5
Early angiographic signs of retinopathy of prematurity requiring treatment 4
Totale 2.792
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.017
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.017
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202053 0 0 0 0 0 0 0 0 0 0 33 20
2020/2021211 4 22 0 18 23 10 25 8 32 12 51 6
2021/2022265 25 20 2 12 10 5 3 59 16 14 33 66
2022/2023706 83 123 64 87 49 80 51 50 85 9 17 8
2023/2024289 20 75 23 11 5 57 14 3 5 19 36 21
2024/2025434 13 18 56 23 38 28 35 26 126 63 8 0
Totale 2.792